Rxcentric

New York, United States Founded: 1999 • Age: 27 yrs Acquired By Veradigm
RxCentric provides of technology-enabled sales and marketing solutions for the life sciences industry.

About Rxcentric

Rxcentric is a Healthcare company based in New York (United States) founded in 1999, and was acquired by Veradigm in July 2003. RxCentric provides of technology-enabled sales and marketing solutions for the life sciences industry. It operates in the Healthcare and Technology sectors. Rxcentric has raised $19 million across 2 funding rounds from investors including Heartwood Partners, Veradigm and inVentiv Health. The company was acqui-hired. Its focus areas include HealthTech, Healthcare IT, Provider and Administrative Solutions. Its competitors include IMS Health, Axtria and Evariant; 2 of its 3 listed competitors have raised funding.

Company details

RxCentric was founded in 1999 and is headquartered in New York, United States. Technology-enabled solutions for sales and marketing in the life sciences sector are delivered, with customized online product promotion used to extend the reach and frequency of offline activities. Clients across North America and Europe are supported, alongside an international venture with Zestica, a Europe-based life sciences consulting firm.

  • Headquarters New York, United States
  • Stage Acquired
  • Sectors
    Healthcare
    Technology
  • Website rxcentric.com
  • Acquired by Veradigm (Jul 2003)
Key Metrics
  • Total Equity Funding
    $19M (USD)

    in 2 rounds

  • Latest Funding Round
    $5M (USD), Series C

    Jan 2002

  • Investors
  • Acquired by
    Veradigm

    (Jul 2003)

Funding Insights of Rxcentric

Rxcentric has successfully raised a total of $19M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $5 million completed in January 2002. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $19M
  • Total Rounds 2
  • Last Round Series C β€” $5M
  • First Round $14M

    (Apr 2000)

  • Investors Count 4

All 2 funding rounds of Rxcentric with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2002$5MSeries C––
Apr 2000$14MSeries B––
Valuation history

5 investors in total: 5 institutional.

Investors in Rxcentric

Rxcentric has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Heartwood Partners, Veradigm and inVentiv Health.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Acquisitions are targeted by this private equity firm in investments.
1982heartwoodpartners.comNorwalk, United States
Early stage healthcare services investments are facilitated by CHL.
chlmedical.comWestport, United States
Private equity single family office
msdcapital.comNew York, United States
Contract research and commercialization services are provided to biopharmaceutical industries.
1999inventivhealth.comBurlington, United States
Cloud-based administrative suite solutions for healthcare organizations
1982veradigm.comChicago, United States
Premium access

Investor details for Rxcentric

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Rxcentric

4 dated milestones of Rxcentric across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded Rxcentric is founded.
  2. Funding First funding round of $14.0M.
  3. Funding Latest funding round, Series C, of $5.0M.
  4. Exit Acquired by Veradigm.

Competitors of Rxcentric

Rxcentric has 3 listed competitors in our database, 2 of them funded. They include IMS Health, Axtria and Evariant.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
imshealth.com1954Danbury, United States17,574
SaaS and AI-based market intelligence is provided for healthcare companies.
axtria.com2009Berkeley Heights, United States$198.74M749
Data analytics and AI solutions are provided for life sciences.
evariant.com2008Farmington, United States$98.83M163
Provides platform for digital marketing solutions
Premium access

Detailed competitors of Rxcentric

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Clinical IT & Data Platforms

3 companies that operate in the same segment as Rxcentric (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M1,746
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Rxcentric

Rxcentric was founded in 1999 and raised its 1st funding round 1 year after it was founded.

Rxcentric is headquartered in New York, United States. It is registered at New York, New York, United States.

Rxcentric is a funded company, having raised a total of $19M across 2 funding rounds to date. The company's 1st funding round was a Series B of $14M, raised on Apr 2000.

RxCentric was founded in 1999 and is headquartered in New York, United States. Technology-enabled solutions for sales and marketing in the life sciences sector are delivered, with customized online product promotion used to extend the reach and frequency of offline activities. Clients across North America and Europe are supported, alongside an international venture with Zestica, a Europe-based life sciences consulting firm.

Rxcentric's top competitors include Axtria, IMS Health and Evariant.

Rxcentric has 5 investors. Key investors include Heartwood Partners, Veradigm, inVentiv Health, CHL Medical Partners, and MSD Capital.

Yes. Rxcentric was acquired by Veradigm in July 2003.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available